Patents by Inventor Christiane Koller

Christiane Koller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stuffy nose deblocking composition having antiviral activity
    Patent number: 10660914
    Abstract: A pharmaceutical composition has a stuffy nose deblocking activity. The composition includes a hyperosmolar aqueous solution of a non-ionic osmolality adjusting agent, optionally in combination with an ionic osmolality adjusting agent, wherein the composition further includes iota-carrageenan and/or kappa-carrageenan as an active antiviral ingredient in an antivirally effective amount, with the proviso that the composition in its ready-for-use formulation contains no more than 0-1.5% w/v of the ionic osmolality adjusting agent. The composition is useful for deblocking a stuffy nose and for prophylactic or therapeutic intervention of a number of viral infections of the upper respiratory tract.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: May 26, 2020
    Assignee: MARINOMED BIOTECH AG
    Inventors: Andreas Grassauer, Eva Prieschl-Grassauer, Angelika Bodenteich, Christiane Koller, Martina Morokutti-Kurz
  • Antiviral composition and method of use
    Patent number: 10376537
    Abstract: Disclosed herein is a method of reducing the risk of a rhinovirus infection, the method includes administering to a subject a composition comprising iota-carrageenan in an antiviral effective amount as an active antiviral ingredient.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: August 13, 2019
    Assignee: MARINOMED BIOTECH AG
    Inventors: Andreas Grassauer, Eva Prieschl-Grassauer, Christiane Koller, Alexander Pretsch
  • Composition effective against viral conjunctivitis
    Patent number: 10220055
    Abstract: The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: March 5, 2019
    Assignee: NICOX S.A.
    Inventors: Eva Prieschl-Grassauer, Martina Morokutti-Kurz, Andreas Grassauer, Sabine Nakowitsch, Angelika Bodenteich, Marielle König-Schuster, Christiane Koller, Frederic Pilotaz
  • STUFFY NOSE DEBLOCKING COMPOSITION HAVING ANTIVIRAL ACTIVITY
    Publication number: 20190060358
    Abstract: A pharmaceutical composition has a stuffy nose deblocking activity. The composition includes a hyperosmolar aqueous solution of a non-ionic osmolality adjusting agent, optionally in combination with an ionic osmolality adjusting agent, wherein the composition further includes iota-carrageenan and/or kappa-carrageenan as an active antiviral ingredient in an antivirally effective amount, with the proviso that the composition in its ready-for-use formulation contains no more than 0-1.5% w/v of the ionic osmolality adjusting agent. The composition is useful for deblocking a stuffy nose and for prophylactic or therapeutic intervention of a number of viral infections of the upper respiratory tract.
    Type: Application
    Filed: July 12, 2016
    Publication date: February 28, 2019
    Applicant: MARINOMED BIOTECH AG
    Inventors: Andreas GRASSAUER, Eva PRIESCHL-GRASSAUER, Angelika BODENTEICH, Christiane KOLLER, Martina MOROKUTTI-KURZ
  • COMPOSITION EFFECTIVE AGAINST VIRAL CONJUNCTIVITIS
    Publication number: 20160331776
    Abstract: The present invention relates to a pharmaceutical composition for use as a medicament in the prophylactic or therapeutic topical treatment of viral eye infections caused by adenovirus of subtype D or influenza A virus of subtype H7. The composition in its ready-for-use formulation comprises iota carrageenan as an active antiviral ingredient and is substantially free of a metal halide salt or contains no more than 0.5% w/v of a metal halide salt.
    Type: Application
    Filed: January 20, 2015
    Publication date: November 17, 2016
    Inventors: Eva PRIESCHL-GRASSAUER, Martina MOROKUTTI-KURZ, Andreas GRASSAUER, Sabine NAKOWITSCH, Angelika BODENTEICH, Marielle KÖNIG-SCHUSTER, Christiane KOLLER, Frederic PILOTAZ
  • Antiviral composition and method of use
    Patent number: 8282969
    Abstract: A method for manufacturing an antiviral pharmaceutical composition for the prophylaxis or treatment of a rhinovirus infection that includes the utilization of iota-, kappa- or lambda-carrageenan or mixtures thereof.
    Type: Grant
    Filed: December 4, 2007
    Date of Patent: October 9, 2012
    Assignee: Marinomed Biotechnologie GmbH
    Inventors: Andreas Grassauer, Eva Prieschl-Grassauer, Christiane Koller, Alexander Pretsch